EnzyTag technology

Our technology offers an entry into linear and cyclic peptide drugs, small proteins, (bio)conjugates, Antibody Drug Conjugates, PROTACs and LYTACs.

Traceless

Aqueous conditions at near neutral pH

Regio- and stereoselective

No side reactions & Improved purity

Reduced synthesis lead time

Efficient scaling to commercial scale

Green & sustainable

Lower COGS and higher volumetric productivity

Representative Examples

Please feel free to contact us

EnzyTag is open to further discussions on technology licensing for commercial purposes.

CONTACT US NOW